IRIS
CARDILE, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 581
EU - Europa 580
AS - Asia 273
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.436
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 580
IE - Irlanda 191
SE - Svezia 162
CN - Cina 130
VN - Vietnam 98
IT - Italia 87
FI - Finlandia 26
GB - Regno Unito 24
AT - Austria 23
DE - Germania 22
IN - India 22
SG - Singapore 20
PL - Polonia 18
FR - Francia 9
CZ - Repubblica Ceca 8
UA - Ucraina 4
BE - Belgio 3
CH - Svizzera 2
EU - Europa 2
IR - Iran 2
CA - Canada 1
EE - Estonia 1
HK - Hong Kong 1
Totale 1.436
Salva come PNG Salva come JPEG
Città #
Chandler 196
Dublin 189
Nyköping 110
Dong Ket 98
Beijing 57
Jacksonville 28
Ashburn 27
Princeton 27
Medford 24
Catania 23
Vienna 23
Cambridge 21
Des Moines 19
New York 19
Warsaw 18
Lancaster 17
Messina 15
Dearborn 14
Houston 14
Hyderabad 13
Shenyang 11
Singapore 11
Jinan 10
Ann Arbor 8
Boardman 8
Brno 8
Bremen 7
Eboli 7
San Mateo 7
Wilmington 7
Fuzhou 6
Taizhou 6
Hebei 5
Pune 5
Haikou 4
Nanjing 4
Taiyuan 4
Tübingen 4
Waverly Hall 4
Brussels 3
Changsha 3
Los Angeles 3
Norwalk 3
Santa Domenica 3
Barcellona Pozzo di Gotto 2
Comiso 2
Guangzhou 2
Jiaxing 2
Lausanne 2
Leawood 2
Milan 2
Munich 2
Ningbo 2
Ragusa 2
Rome 2
Seattle 2
Zhengzhou 2
Ardabil 1
Bangalore 1
Boscobel 1
Brindisi 1
Chaoyang 1
Corbetta 1
Edinburgh 1
Edmonton 1
Fairfield 1
Hangzhou 1
Hanover 1
Helsinki 1
Hong Kong 1
Lannoy 1
Lappeenranta 1
Mumbai 1
Nanchang 1
Pescara 1
Phoenix 1
Redmond 1
Riva 1
Shenzhen 1
Stoke-on-Trent 1
Tallinn 1
Tamworth 1
Taunton 1
Tianjin 1
Vittoria 1
Totale 1.147
Salva come PNG Salva come JPEG
Nome #
111In-Pentetreotide in neuroendocrine tumours: comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 96
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 95
111In-Pentetreotide therapy in patients with inoperable benign intracranial tumors. 90
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 78
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 77
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 70
Increased 177Lu-DOTATATE Uptake in Paget Disease 66
Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature 64
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan 62
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 60
Meningocele mimicking a metastasis of papillary thyroid carcinoma 58
A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions 57
Repeated administrations of peptide receptor radionuclide therapy: long term follow-up of renal function. 57
Peptide receptor radionuclide therapy in patients with pulmonary neuroendocrine tumors: our experience 52
Long term follow-up of renal function in patients who underwent repeated peptide receptor radionuclide therapy 51
Calibration of a gamma camera for 177Lu quantitative imaging: measurements of sensitivity and scatter correction factors in broad beam geometry 49
Demonstration of unknown primitive neuroendocrine tumor by post-treatment imaging with high activities of radiolabeled somatostatin analogues 48
Paget disease revealed by Lu-177-DOTATATE post-therapy whole-body scan. 47
Is Detection of Additional Lesions in Post-Peptide ReceptorRadionuclide Therapy Scans With Respect to DiagnosticImaging Only Due to Different Affinity of Ligands?A Report of Discordance Between Diagnostic and Posttherapy Imaging Using the Same Ligand 43
Our experience with peptide receptor radionuclide therapy in patients affected by pulmonary neuroendocrine tumors 43
Differences in the sensitivity of pretherapy and post-therapy scans in patients undergoing peptide receptor radionuclide therapy 38
Usefulness of 111In-pentetreotide therapy in patients with inoperable benign intracranial tumors 38
Post-therapy whole-body scan in patients who underwent peptide receptor radionuclide therapy using 111In-Pentetreotide reveals more lesions than diagnostic imaging with gamma emitters 38
Renal function evaluation in patients undergoing repeated peptide receptor radionuclide therapy 35
null 16
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose 12
Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study 6
Role of Nutrition in the Etiopathogenesis and Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in a Group of Obese Adults 5
Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients 5
Febrile Urinary Tract Infections in Children: The Role of High Mobility Group Box-1 3
Gastroparesis in Adolescent Patient with Type 1 Diabetes: Severe Presentation of a Rare Pediatric Complication 3
What about the Use of Ice Cream as a Supplementary Diet in Chronic Kidney Disease? A Case–Control Study 1
Improving Neuroplasticity through Robotic Verticalization Training in Patients with Minimally Conscious State: A Retrospective Study 1
Challenges and pitfalls in the management of endocrine toxicities from immune checkpoint inhibitors: a case presentation of synchronous thyrotoxicosis and primary adrenal insufficiency in a melanoma patient 1
Totale 1.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 0 0 0 2 0 13 9 12 7 57 13 4
2020/2021213 9 1 36 5 21 7 4 4 3 7 14 102
2021/2022195 2 35 3 7 8 1 18 7 3 33 16 62
2022/2023643 56 74 27 77 51 64 10 37 224 0 16 7
2023/2024160 7 16 9 20 11 47 1 2 1 15 5 26
2024/202516 13 3 0 0 0 0 0 0 0 0 0 0
Totale 1.465